XETRA:GXI

Gerresheimer AG · XETRA · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-07 19:04 UTC

Last close

n/aEUR

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-13.8%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
-4.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.48Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.2%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.23 against 0.58 on the market's range.

Five bars, one line

lens 7 of 9

1.40x

-5.28x

-30.76x

1.43x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.40x
Its own average over 10 years, 1.66B.
Profit-5.28x
Its own average over 10 years, 60.6M.
Free cash flow-30.76x
Its own average over 10 years, 3.2M.
Debt1.43x
Its own average over 10 years, 1.12B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -30.76 times.

The filed years, as a table

Each line is 100 at 2016-11-30, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-11-30	100.0	100.0	100.0
2017-11-30	98.0	82.9	100.0
2018-11-30	99.4	106.0	100.0
2019-11-30	101.2	66.4	100.0
2020-11-30	103.1	72.8	100.0
2021-11-30	108.9	68.9	100.0
2022-11-30	132.1	79.0	100.0
2023-11-30	144.7	95.5	106.2
2024-11-30	148.0	90.2	110.0
2025-11-30	168.7	-263.3	110.0

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

Figures behind the shape

Growth

10.3%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate10.3%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
One-year change in net income-391.9%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Returns on capital

-29.6%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity-29.6%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets-7.1%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

18.3%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin18.3%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin-9.0%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin-13.8%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-4.3%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

1.0x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
Price to book1.0x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA33.1x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

1.48

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equity1.48
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio0.81
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score0.77
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

0.2%

more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06

Dividend yield0.2%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio-42.1x
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.